Submit Deal

VIR BIOTECHNOLOGY

Summary

Vir Biotechnology is a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 204 M

Avg. Deal Size£ 204 M

Market Context

Senior Management

Sort

Target: VIR BIOTECHNOLOGY

Bidder: GLAXOSMITHKLINE PLC

3 Service Providers

2 Dealmakers

£ 203 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy